Question 1

What is VistaGen Therapeutics Inc (VTGN) stock price today?

Accepted Answer

VistaGen Therapeutics Inc (VTGN) currently trades at $0.61 per share. The stock has a market capitalization of $23.64M and a P/E ratio of —x.

Question 2

Is VTGN stock a buy, sell, or hold in 2026?

Accepted Answer

Based on WallStSmart's proprietary analysis, VistaGen Therapeutics Inc has a Smart Value Score of 34/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

Question 3

What is VistaGen Therapeutics Inc's revenue and earnings?

Accepted Answer

VistaGen Therapeutics Inc has trailing twelve-month (TTM) revenue of $789000.00 with profit margins of 0.00%. Earnings per share (EPS) is $-1.90.

Question 4

Is VTGN stock overvalued or undervalued?

Accepted Answer

Based on our DCF model, VistaGen Therapeutics Inc's intrinsic value is $1.88, representing a margin of safety of 71.01%. The stock currently trades at a P/E of —x.

Metric	2022	2023	2024	2025	TTM
Revenue	$1.11M	$-227300.00	$1.06M	$486000.00	$789000.00
Net income	$-47.76M	$-59.25M	$-29.36M	$-51.42M	$-18.90M
EPS	—	—	—	—	$-1.90
Free cash flow	$-45.46M	$-49.93M	$-25.87M	$-42.29M	$-17.69M
Profit margin	-4,307.19%	26,065.86%	-2,759.59%	-10,579.84%	—

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
VTGN	$23.64M	34	4.7	2.5	6.7	5.0	+71.01%	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

VistaGen Therapeutics Inc

WallStSmart proprietary scores

Price targets

Price chart

X-Ray snapshot

Key financials

Peer comparison

Smart narrative

Frequently asked questions

Company info

Quick metrics

Performance

Compare